Abstract: A device can clean at least one pipetting needle with a washing station. In the device, the inside and an outside of the pipetting needle are brought into contact at least for a portion with a washing liquid, at least temporarily during a cleaning process, and with at least one movement apparatus, by which a relative movement is brought about between the pipetting needle and the washing station at least temporarily before, after, or during the cleaning process. The device has a drying device, which subjects at least one region of the pipetting needle brought into contact with washing liquid during the cleaning process to at least one flow of a drying agent.

Abstract: Trichinella can be detected in a tissue extract sample. A suitable kit includes (a) a detection carrier containing a first antibody against one or more antigens of Trichinella, and (b) (i) a second antibody against one or more antigens of Trichinella, wherein the second antibody is bound to a signal molecule, or (b) (ii) contains one or more antigens of Trichinella bound to a signal molecule, wherein the antigens of (b) (ii) are configured so as to dissolve binding of the antigens of (a) to the first antibody by competitive displacement.

Abstract: A polypeptide contains laminin beta-4 and a carrier contains the polypeptide. An antibody, preferably autoantibody, is against laminin beta-4. Furthermore, use of the polypeptide, carrier or autoantibody for the diagnosis of a disease, and a method with the step of detecting an autoantibody against laminin beta-4 in a sample are described.

Abstract: A device for incubating an immunoblot strip (6) includes at least one incubation channel (1) into which an elongate immunoblot strip (6) having at least one biological material on its front is inserted with its back facing a channel base (2). An agitating means (7), with which the immunoblot strip (6) is agitatable around a transverse axis (8) of the strip (6) at least at times during incubation via an agitating device (7). For handling and/or grouping incubation channels (1) with immunoblot strips (6) inserted, a rack (3) for taking up at least two incubation channels (1) is provided. The rack (3) is in operative connection with said agitating means (7) via load transmission points.

Abstract: A method is used for diagnosing a disease by detecting in a sample with antibodies from a patient an autoantibody binding to DAGLA.

Abstract: The invention relates to an incubation tray having a depression formed by the walls of the incubation tray and having a base, wherein the incubation tray has a means for drawing off liquid on at least one longitudinal end of the depression, preferably an opening which opens into an outlet channel on the longitudinal end of the depression, particularly preferably in a wall of the incubation tray, wherein the opening and the outlet channel are designed such that negative pressure can be applied, wherein the incubation tray is pivotable about the transverse axis of the incubation tray, and wherein the incubation tray can be equipped with a support.

Abstract: A method is used for acquiring and displaying an immunofluorescence image of a biological sample. During a first operating state, the sample is continuously illuminated using the excitation radiation. A relative position between the sample and an optical system, which guides the fluorescent radiation to an image sensor, is changed in dependence on a movement gesture of a user, and a corresponding digital image is displayed. Upon detection of a termination of the movement gesture, a change is made from the first operating state to a second operating state. In the second operating state, the sample is firstly illuminated using the excitation radiation to excite the fluorescent radiation of the fluorescent pigment. An acquisition of fluorescent radiation emitted by the sample then takes place and a corresponding, further digital image is generated.

Abstract: A method is for producing biological material-coated solid-phase fragments. The method first provides a biological material-coated solid-phase support in a fragmented state and the biological material-coated solid-phase fragment adhered to a film. Then, a tensile stress is generated on the film, which is then contacted with a lifting head to pre-detach the biological material-coated solid-phase fragment from the film. The fragment is then taken off from the film. A device for producing the biological material-coated solid-phase fragment includes a tensile-stress unit, a lifting-head unit and a removal unit.

Abstract: A recombinant polypeptide can be used in the diagnosis of the presence of a Zika virus in a patient. The recombinant polypeptide includes SEQ ID NO1 or a variant thereof, where the recombinant polypeptide is a monomer, a dimer, or a hexamer.

Abstract: An incubation device has multiple rocking platforms with each platform pivotally mounted about a respective axis. Each rocking platform has a respective receiving device for mechanically reversibly receiving a respective incubation channel. The device also has a common drive unit for common respective rocking movements of each platform from a zero position through with a specific angle range as a result of movement of the drive unit. Each rocking platform is coupled to the drive unit via a respective coupling mechanism, and each coupling mechanism elastically and resiliently couples the respective rocking platform to the drive unit, such that when the rocking platform is restrained, despite continuation of the drive movement, the rocking platform remains motionless in a fixed position. After release of the restraint on the rocking platform, the rocking platform resumes the rocking movement with the specific angle range.

Abstract: An elongated incubation trough has an indentation open toward a top end as well as a bottom. The indentation has a first receiving area to receive an elongated test strip as well as a second receiving area to receive an end section of a fluid line. The second receiving area is in fluidic communication with the first receiving area. A maximum width of the second receiving area at bottom height is greater than a maximum width of the first receiving area at bottom height.

Abstract: The invention relates to a device and to a method for storing and transporting a bodily fluid sample, comprising a support element (2), which forms a main body. At least one sorption element (3), which has a defined filling volume and is suitable for receiving a drop of the bodily fluid, and an overflow reservoir (4), which is adjacent to the sorption element (3) and which receives the bodily fluid from the sorption element (3) as soon as the filling volume of the sorption element (3) is filled, are fastened to the support element. The technical solution according to the invention is characterized in that at least one predetermined breaking point (5) is provided, which is designed in such a way that the sorption element (3) can be manually detached from the support element (1) and/or from the overflow reservoir (4) without an auxiliary tool.

Abstract: The present invention relates to a method for the diagnosis of a disease comprising contacting a donor tissue section with a liquid capable of extracting an antibody from said donor tissue section and contacting said liquid with an acceptor material comprising an antigen, followed by detection of a complex comprising the antibody and the antigen, and a diagnostically useful carrier comprising a donor tissue section and an acceptor material comprising an antigen.

Abstract: The present invention relates to a pressure-tight storage vessel containing a liquid, wherein the storage vessel has an inner floor and an upper side and is closed in a pressure-sealing manner by a closure, and wherein the nature of the storage vessel allows pressure-sealing piercing with at least two hollow needles; and to a method for transferring a liquid from a storage vessel to a reaction vessel, the method comprising the following steps: supplying the storage vessel according to the invention, pressure-sealing piercing with a first hollow needle, which is connected to a rinsing-liquid tank, and pressure-sealing piercing with a second hollow needle, which is connected to the reaction vessel, introducing rinsing liquid from the rinsing-liquid tank, via the first hollow needle, into the storage vessel, the liquid being driven out of the storage vessel, via the second hollow needle, into the reaction vessel; and to an apparatus which is suitable for implementing the method according to the invention.

Abstract: A method for diagnosing a limbic encephalitis, PNS, encephaloymyelitis, leukoencephalopathy, retinitis or optic atrophy, includes detecting a bornavirus in a sample, preferably from the group comprising mammalian 2 bornavirus, even more preferably VSBV-1, and mammalian 1 bornavirus, even more preferably BoDV-1; to a carrier containing a means for the capture of an antibody against at least one polypeptide selected from the group of BoDV-1-N, BoDV-1-P, VSBV-N and VSBV-P. A kit contains the carrier and a means for the detection of a captured antibody and a control for the detection of the presence of a sample. The carrier or kit or of a primer can be used for the detection of a bornavirus or a probe can be used for the diagnosis of an encephalitis, for the prognostication of post-transplantation complications, for the monitoring of a therapy of an encephalitis or of post-transplantation complications or for the differentiation between an autoimmune encephalitis and an encephalitis caused by infection.

Abstract: Trichinella can be detected in a tissue extract sample. A suitable kit includes (a) a detection carrier containing a first antibody against one or more antigens of Trichinella, and (b) (i) a second antibody against one or more antigens of Trichinella, wherein the second antibody is bound to a signal molecule, or (b) (ii) contains one or more antigens of Trichinella bound to a signal molecule, wherein the antigens of (b) (ii) are configured so as to dissolve binding of the antigens of (a) to the first antibody by competitive displacement.

Abstract: An Aspergillus infection is diagnosed in a patient by detecting in a sample a proteinaceous antigen derived from mycelium of a pathogenic Aspergillus strain, wherein the sample is contacted with a first antibody binding specifically to said antigen and wherein any antigen bound to said first antibody is detected by way of a non-membrane based immunoassay, preferably selected from an ELISA and a bead-based assay. An antibody binding to a proteinaceous antigen derived from mycelium of a pathogenic Aspergillus strain is used for increasing the reliability of an immunoassay or the diagnosis of an Aspergillus infection in a patient. A further method includes coating a diagnostic device with a first antibody binding specifically to a proteinaceous antigen derived from mycelium of a pathogenic Aspergillus strain.

Abstract: A diagnostically useful carrier can include a means for capturing Neurogranin, a means for capturing BACE1 and preferably a means for capturing one or more additional biomarkers. The diagnostically useful carrier can be part of a kit. The kit or the carrier can be used in contacting a sample from a subject with a means for capturing Neurogranin, isolating the means for capturing Neurogranin from the sample, contacting a sample from a subject with a means for capturing BACE1, and isolating the means for capturing BACE1 from the sample. The diagnosis aims to distinguish a neurodegenerative disease, preferably mild Alzheimer's disease, and depression with or without cognitive impairment.

Abstract: A device can clean at least one pipetting needle with a washing station. In the device, the inside and an outside of the pipetting needle are brought into contact at least for a portion with a washing liquid, at least temporarily during a cleaning process, and with at least one movement apparatus, by which a relative movement is brought about between the pipetting needle and the washing station at least temporarily before, after, or during the cleaning process. The device has a drying device, which subjects at least one region of the pipetting needle brought into contact with washing liquid during the cleaning process to at least one flow of a drying agent.

Abstract: An in vitro method can diagnose membranous nephropathy patient. The method includes detecting in a biological sample obtained from the patient one or more autoantibodies recognizing a Thrombospondin, Type I. Domain Containing 7A (THSD7A) protein.